Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT06204445
Active, not recruiting Not applicable

Interindividual Variation in Response to Green Coffee

NCT06204445 · tracked via the Priya Life Science Spain tracker
Sponsor
Instituto de Ciencia y Tecnología de Alimentos y Nutrición
Phase
Not applicable
Started
2022-12-13
Last updated
2024-12-11

Condition(s) studied

Overweight and Obesity

Investigational drug(s) / intervention(s)

Green coffeeRoasted coffee

Green coffee: Each cup of coffee provides approximately 400 mg of hydroxycinnamic acids.

Roasted coffee: Each cup of coffee provides approximately 150 mg of hydroxycinnamic acids.

Study summary

The study is a multifaceted approach to investigate the effects of regular consumption of green coffee rich in polyphenols (hydroxycinnamic acids) on weight, body composition, cardiometabolic and inflammatory biomarkers in a sample population of overweight and obese people aimed at identifying a population of responders to green coffee experimenting the highest benefit from this product, and to contribute to the understanding of the influence of some of the main factors on the response to green coffee and their association with the differences between individuals (high-responders vs. low-responders).

Eligibility

Sex
ALL
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Body mass index 25-35 kg/m2 Exclusion Criteria: * Smoking * Vegetarian/Vegan * Pregnant/lactating women * On prescription drugs other than for thyroid/hypertension/dyslipemia, or changes in dosage in the last 3 months. * Consumption of vitamins or dietary supplements * On weight-reduction dietary regime or physical training to reduce body weight * Having taken antibiotics 3 months before starting the intervention * Intestinal, hepatic or renal diseases, coffee intolerance

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Instituto de Ciencia y Tecnología de Alimentos y Nutrición Madrid Madrid

More Instituto de Ciencia y Tecnología de Alimentos y Nutrición trials in Spain

Antidiabetic Effect of Olive Pomace Oil Recruiting

Other trials for the same condition

Inhibitory Control Training for Excess Weight: Behavioural, Cognitive and Anthropometric Changes Recruiting
Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). Recruiting
Inhibitory Control Training and iTBS for Excess Weight: Behavioral and Brain Changes (InhibE). Recruiting
Maternal Betaine Supplementation During Breastfeeding Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06204445 on ClinicalTrials.gov ↗ ← All trials in Spain